Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter U Fischer

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Plos Neglected Tropical Diseases|September 3, 2024
A novel antigen biomarker for detection of high-level of Loa loa microfilaremiaSarah E Greene, Yuefang Huang, Kerstin Fischer, et al.
Parasites & Vectors|July 15, 2015
A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administrationThishan C Yahathugoda, Taniawati Supali, Ramakrishna U Rao, et al.
Acta Tropica|April 11, 2022
Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern LiberiaObiora A Eneanya, Lincoln Gankpala, Charles W Goss, et al.
Plos Neglected Tropical Diseases|January 27, 2025
Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New GuineaKrufinta Bun, Benedict Mode, Melinda Susapu, et al.
Frontiers in Parasitology|January 16, 2025
Identification of biomarker candidates for filarial parasite infections by analysis of extracellular vesiclesDevyn Yates, Lucia S Di Maggio, Bruce A Rosa, et al.
The Lancet. Infectious Diseases|May 9, 2025
Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trialGuibehi Benjamin Koudou, Catherine M Bjerum, Foungoye Allassane Ouattara, et al.
Plos Neglected Tropical Diseases|March 10, 2025
Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New GuineaJannet A Tobon Ramos, Tobias Maure, Lenore Carias, et al.
Plos Neglected Tropical Diseases|July 1, 2025
Genetic structuring and estimation of reproductive adults in Onchocerca volvulus: A genome-wide analysis across hosts and regionsPawan Kumar, Young-Jun Choi, Kerstin Fischer, et al.
The American Journal of Tropical Medicine and Hygiene|June 3, 2025
An Antibody Biomarker Associated with Onchocerca volvulus Microfilariae Identified by Proteomic Analysis of Parasite Tissues Isolated from Paraffin Embedded O. volvulus Nodules by Laser Capture MicrodissectionSarah E Greene, Kerstin Fischer, Lucia S Di Maggio, et al.
Scientific Reports|August 22, 2023
The proteome of extracellular vesicles of the lung fluke Paragonimus kellicotti produced in vitro and in the lung cystLucia S Di Maggio, Kerstin Fischer, Devyn Yates, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Plos Neglected Tropical Diseases|September 3, 2024
A novel antigen biomarker for detection of high-level of Loa loa microfilaremiaSarah E Greene, Yuefang Huang, Kerstin Fischer, et al.
Parasites & Vectors|July 15, 2015
A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administrationThishan C Yahathugoda, Taniawati Supali, Ramakrishna U Rao, et al.
Acta Tropica|April 11, 2022
Community-based trial assessing the impact of annual versus semiannual mass drug administration with ivermectin plus albendazole and praziquantel on helminth infections in northwestern LiberiaObiora A Eneanya, Lincoln Gankpala, Charles W Goss, et al.
Plos Neglected Tropical Diseases|January 27, 2025
Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New GuineaKrufinta Bun, Benedict Mode, Melinda Susapu, et al.
Frontiers in Parasitology|January 16, 2025
Identification of biomarker candidates for filarial parasite infections by analysis of extracellular vesiclesDevyn Yates, Lucia S Di Maggio, Bruce A Rosa, et al.
The Lancet. Infectious Diseases|May 9, 2025
Moxidectin combination therapies for lymphatic filariasis: an open-label, observer-masked, randomised controlled trialGuibehi Benjamin Koudou, Catherine M Bjerum, Foungoye Allassane Ouattara, et al.
Plos Neglected Tropical Diseases|March 10, 2025
Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New GuineaJannet A Tobon Ramos, Tobias Maure, Lenore Carias, et al.
Plos Neglected Tropical Diseases|July 1, 2025
Genetic structuring and estimation of reproductive adults in Onchocerca volvulus: A genome-wide analysis across hosts and regionsPawan Kumar, Young-Jun Choi, Kerstin Fischer, et al.
The American Journal of Tropical Medicine and Hygiene|June 3, 2025
An Antibody Biomarker Associated with Onchocerca volvulus Microfilariae Identified by Proteomic Analysis of Parasite Tissues Isolated from Paraffin Embedded O. volvulus Nodules by Laser Capture MicrodissectionSarah E Greene, Kerstin Fischer, Lucia S Di Maggio, et al.
Scientific Reports|August 22, 2023
The proteome of extracellular vesicles of the lung fluke Paragonimus kellicotti produced in vitro and in the lung cystLucia S Di Maggio, Kerstin Fischer, Devyn Yates, et al.
Pageof 11